INFU logo

InfuSystem Holdings (INFU)

Profile

Full Name

InfuSystem Holdings, Inc.

Ticker Symbol

INFU

Exchange

NYSE American

Sector

Healthcare

Industry

Medical Instruments & Supplies

Country

United States

IPO

December 27, 2007

Indexes

Not included

Website

http://www.infusystem.com

Employees

502

Key Details

Price

$4.98(+1.43%)

Market cap

$104.63M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$134.86M(+7.22% YoY)

Annual EPS

$0.11(+175.00% YoY)

PE ratio

49.80

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$4.98
INFU price is $4.98

30-Day Relative Volume

0.70
INFU 30-day relative volume is 0.70

Price Performance

Price Most recent change

+1.43%
INFU price was up +1.43% on Apr 11, 2025

Price YTD change

-41.07%
INFU price is down -41.07% since January 1st

Price 1-year change

-37.44%
INFU price is down -37.44% year-on-year

Price 3-year change

-42.63%
INFU price is down -42.63% over the past 3 years

Price Range

Price All-time high

$23.26
INFU price is currently -78.59% below its historical high of $23.26

Price 3-year low

$4.61
INFU price is currently +8.03% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$104.63M
INFU market capitalization is $104.63 million

Market cap 3-year change

-41.32%
INFU market capitalization is down -41.32% over the past 3 years

Market cap All-time high

$469.14M
INFU market capitalization is currently -77.70% below its historical high of $469.14 million

Market cap sector rank

49.38%
INFU market capitalization is higher than 49.38% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-1.2%
INFU shares outstanding is down -1.2% year-on-year

Shares Outstanding 3-Year Change

+2.28%
INFU shares outstanding is up +2.28% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.09
INFU beta is 1.09

200-day SMA

$7.12
INFU price is currently -30.04% below its 200-day simple moving average

50-day SMA

$6.61
INFU price is currently -24.68% below its 50-day simple moving average

RSI

34.10
INFU 14-day relative strength index is 34.10

Volume

0.70
INFU 30-day relative volume is 0.70

ATR

$0.34
INFU average true range is $0.34

10-day Historical Volatility

51.31%
INFU 10-day historical volatility is 51.31%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$134.86M
INFU annual revenue is $134.86 million

Revenue Analysts estimate

$146.48M
INFU annual revenue is currently -7.93% lower than the consensus analysts' forecast

Revenue 1-year change

+7.22%
INFU annual revenue is up +7.22% year-on-year

Revenue Sector rank

59.35%
INFU annual revenue is higher than 59.35% of companies in Healthcare sector

EPS

EPS

$0.11
INFU annual earnings per share is $0.11

EPS Analysts estimate

$0.15
INFU annual earnings per share is currently -26.67% lower than the consensus analysts' forecast

EPS 1-year change

+175%
INFU annual earnings per share is up +175% year-on-year

EPS Sector rank

84.06%
INFU annual earnings per share is higher than 84.06% of companies in Healthcare sector

Profit

Gross profit

$70.40M
INFU annual gross profit is $70.40 million

Gross margin

52.20%
INFU annual gross profit margin is 52.20%

Operating profit

$6.89M
INFU annual operating income is $6.89 million

Operating margin

5.11%
INFU annual operating profit margin is 5.11%

Net income

$2.35M
INFU annual net profit is $2.35 million

Net margin

1.74%
INFU annual net profit margin is 1.74%

Expenses

Total expenses

$127.97M
INFU annual total expenses is $127.97 million

Operating expenses

$63.51M
INFU annual total operating expenses is $63.51 million

Cost of goods sold

$64.46M
INFU annual cost of goods sold is $64.46 million

Selling, general & administrative expenses

$62.52M
INFU annual SGA is $62.52 million

Depreciation and amortization

$12.50M
INFU annual depreciation & amortization is $12.50 million

Interest expense

$1.78M
INFU annual interest expense is $1.78 million

Income tax

$2.71M
INFU annual income tax is $2.71 million

EBIT & EBITDA

EBIT

$6.84M
INFU annual earnings before interest & taxes is $6.84 million

EBITDA

$19.34M
INFU annual EBITDA is $19.34 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$103.61M
INFU annual total assets is $103.61 million

Non current assets

$71.45M
INFU annual long term assets is $71.45 million

Current assets

$32.16M
INFU annual total current assets is $32.16 million

Cash and cash equivalents

$527.00K
INFU annual cash & cash equivalents is $527.00 thousand

Accounts receivable

$21.16M
INFU annual accounts receivable is $21.16 million

Inventory

$6.53M
INFU annual inventory is $6.53 million

Liabilities

Total liabilities

$46.09M
INFU annual total liabilities is $46.09 million

Long term liabilities

$28.42M
INFU annual total long term liabilities is $28.42 million

Current liabilities

$17.66M
INFU annual total current liabilities is $17.66 million

Accounts payable

$9.85M
INFU annual accounts payable is $9.85 million

Debt

Total debt

$28.42M
INFU annual total debt is $28.42 million

Total debt 1-year change

-18.56%
INFU annual total debt is down -18.56% year-on-year

Long term debt

$28.42M
INFU annual long term debt is $28.42 million

Short term debt

-
INFU annual short term debt value is unknown

Equity & Capital

Shareholders equity

$57.53M
INFU annual stockholders equity is $57.53 million

Book value

$57.53M
INFU annual book value is $57.53 million

Retained earnings

-$57.46M
INFU annual retained earnings is -$57.46 million

Working capital

$14.50M
INFU annual working capital is $14.50 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$20.46M
INFU annual cash flow from operations is $20.46 million

Cash from operations 1-year change

+82.3%
INFU annual cash flow from operations is up +82.3% year-on-year

Cash from investing

-$13.24M
INFU annual cash flow from investing activities is -$13.24 million

Cash from investing 1-year change

-96.6%
INFU annual cash flow from investing activities is down -96.6% year-on-year

Cash from financing

-$6.92M
INFU annual cash flow from financing activities is -$6.92 million

Cash from financing 1-year change

-56.55%
INFU annual cash flow from financing activities is down -56.55% year-on-year

CAPEX

CAPEX

$17.83M
INFU annual capital expenditures is $17.83 million

CAPEX 1-year change

+60.41%
INFU annual capital expenditures is up +60.41% year-on-year

Free Cash Flow

Free cash flow

$2.63M
INFU annual free cash flow is $2.63 million

Free cash flow 1-year change

+2377.36%
INFU annual free cash flow is up +2377.36% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

52.20%
INFU annual gross profit margin is 52.20%

Operating margin

5.11%
INFU annual operating profit margin is 5.11%

Net margin

1.74%
INFU annual net profit margin is 1.74%

ROA & ROE

ROA

2.27%
INFU annual return on assets is 2.27%

ROE

4.27%
INFU annual return on equity is 4.27%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

49.80
INFU price to earnings ratio is 49.80

PE ratio Sector rank

79.41%
INFU price to earnings ratio is higher than 79.41% of companies in Healthcare sector

PB Ratio

PB ratio

1.82
INFU price to book ratio is 1.82

PB ratio Sector rank

60.77%
INFU price to book ratio is higher than 60.77% of companies in Healthcare sector

PS Ratio

PS ratio

0.78
INFU price to sales ratio is 0.78

PS ratio Sector rank

23.85%
INFU price to sales ratio is higher than 23.85% of companies in Healthcare sector

Enterprise value

Enterprise value

$132.52M
INFU enterprise value is $132.52 million

Enterprise value Sector rank

53.18%
INFU enterprise value is higher than 53.18% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

6.85
INFU EV/EBITDA is 6.85

EV/EBITDA Sector rank

79.58%
INFU EV/EBITDA is higher than 79.58% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.82
INFU annual current ratio is 1.82

Quick ratio

1.45
INFU annual quick ratio is 1.45

Leverage

Debt to equity

0.41
INFU annual debt to equity ratio is 0.41

Interest coverage ratio

3.85
INFU annual interest coverage ratio is 3.85

Risk & Stability

Piotroski F-Score

7
INFU piotroski f-score is 7

Altman Z-Score

2.27
INFU altman z-score is 2.27

Analyst ratings

Recent major analysts updates

Sep 26, 24 B. Riley Securities
Buy
Apr 26, 21 Northland Capital Markets
Outperform
Aug 31, 20 Craig-Hallum
Buy

Institutional Ownership

Similar stocks

Contineum Therapeutics Class A (CTNM)
KRMD logo
KORU Medical Systems (KRMD)
ZTEK logo
Zentek (ZTEK)
LUCD logo
Lucid Diagnostics (LUCD)
MCRB logo
Seres Therapeutics (MCRB)
SLS logo
SELLAS Life Sciences (SLS)
AIRS logo
AirSculpt Technologies (AIRS)
LCTX logo
Lineage Cell Therapeutics (LCTX)
CSBR logo
Champions Oncology (CSBR)
  • What is the ticker symbol for InfuSystem Holdings?
  • Does InfuSystem Holdings pay dividends?
  • What sector is InfuSystem Holdings in?
  • What industry is InfuSystem Holdings in?
  • What country is InfuSystem Holdings based in?
  • When did InfuSystem Holdings go public?
  • Is InfuSystem Holdings in the S&P 500?
  • Is InfuSystem Holdings in the NASDAQ 100?
  • Is InfuSystem Holdings in the Dow Jones?
  • When was InfuSystem Holdings's last earnings report?
  • When does InfuSystem Holdings report earnings?
  • Should I buy InfuSystem Holdings stock now?

What is the ticker symbol for InfuSystem Holdings?

The ticker symbol for InfuSystem Holdings is NYSE American:INFU

Does InfuSystem Holdings pay dividends?

No, InfuSystem Holdings does not pay dividends

What sector is InfuSystem Holdings in?

InfuSystem Holdings is in the Healthcare sector

What industry is InfuSystem Holdings in?

InfuSystem Holdings is in the Medical Instruments & Supplies industry

What country is InfuSystem Holdings based in?

InfuSystem Holdings is headquartered in United States

When did InfuSystem Holdings go public?

InfuSystem Holdings's initial public offering (IPO) was on December 27, 2007

Is InfuSystem Holdings in the S&P 500?

No, InfuSystem Holdings is not included in the S&P 500 index

Is InfuSystem Holdings in the NASDAQ 100?

No, InfuSystem Holdings is not included in the NASDAQ 100 index

Is InfuSystem Holdings in the Dow Jones?

No, InfuSystem Holdings is not included in the Dow Jones index

When was InfuSystem Holdings's last earnings report?

InfuSystem Holdings's most recent earnings report was on Mar 4, 2025

When does InfuSystem Holdings report earnings?

The next expected earnings date for InfuSystem Holdings is May 9, 2025

Should I buy InfuSystem Holdings stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page